I consider watching our daughter struggle through the symptoms of Lambert-Eaton myasthenic syndrome (LEMS) one of the most difficult aspects of my life. As I look back on the last two and a half years since Grace began showing symptoms, I realize how I haphazardly stumbled through the five stages of...
people News
ARLINGTON, Va. — The ALS Association proudly announces the largest single gift in its history from the estate of the late philanthropist Hugh Hoffman. The $58 million gift will profoundly impact the lives of people living with ALS and their loved ones, advancing the ALS Association’s goal of making amyotrophic...
CAMBRIDGE, Mass. – Hunterian Medicine LLC, a gene-editing and gene therapy company, has been awarded a Therapeutics Development Award by the Cystic Fibrosis Foundation. The award, through the Foundation’s Path to a Cure initiative that seeks to replace, restore or repair cystic fibrosis transmembrane conductance regulator (CFTR) genes, will support Hunterian’s concentrated efforts...
New York, NY — The Icahn School of Medicine at Mount Sinai has been awarded a grant of more than $4 million from The Leona M. and Harry B. Helmsley Charitable Trust to support an innovative research project aimed at understanding the early stages of Crohn’s disease before noticeable symptoms...
PHILADELPHIA – iECURE, a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet need, today announced it has appointed Brian Di Donato, MBA to its Board of Directors. Mr. Di Donato has more than 20 years of financial and leadership experience and currently serves as...
The midfielder is auctioning off his signed match-worn shirt from Manchester City’s 2-1 win over Borussia Dortmund in the first leg of our Champions League quarter-final, with all proceeds being used to help fund Dilara Abanoglu’s life-saving surgery. Dilara was diagnosed with Ollier’s Disease – a skeletal disorder which affects...
PALO ALTO, Calif. – Immune-Onc Therapeutics, Inc. (“Immune-Onc”), a clinical-stage cancer immunotherapy company developing novel biotherapeutics targeting immunosuppressive myeloid checkpoints, today announced the appointment of Stuart Lutzker, M.D., Ph.D. to Immune-Onc’s Scientific Advisory Board (SAB). A pioneer of the biotech industry, Dr. Lutzker brings decades of oncology drug discovery and...
ROCKVILLE, Md. – Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, announced today that its’ academic collaborator, Dr. John Sampson of Duke University’s Department of Neurosurgery, has been recognized as a World Expert in Glioblastoma by Expertscape, an online resource that...
LUND, Sweden – Immunovia AB (publ.) announced today that the Company’s President and Chief Executive Officer, Patrik Dahlen, has informed the Board of Directors of his intention to step down, for personal reasons. The search for a new CEO will start immediately. Although Patrik Dahlen will remain with the company for another six months...
Ottawa, Canada – Georges Wistaff calls CHEO his family’s second home. They have made more than 100 trips there over the last decade, mostly because of health issues involving their 10-year-old son, Antony. Antony was born prematurely and underwent emergency surgery soon after. That was the start of a medical...